Pharmaceutical Industry Business Confidence Report H2 2016
The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H2 2016 (July 2016–December 2016). Companies are slightly optimistic about economic conditions in North America and the Asia-Pacific due to positive momentum in the US, firm domestic demand, and strong government expenditure in India. The pharmaceutical industry is expected to record higher expenditure towards new product development and mergers and acquisitions in H2 2016 as compared to H1 2016. Moreover, executives with...
View full press release